Medical Devices Could Face Cyber Threats, Warns FDA
Michael Harper for redOrbit.com – Your Universe Online The conversation of cyber security has largely focused on the issue of protecting national security and the private sector. Without proper preventive measures in place, hackers, spies and...
Latest FDA Stories
NEW FDA-APPROVED INTRAOCULAR LENS CORRECTS ASTIGMATISM AND IMPROVES NEAR, INTERMEDIATE AND DISTANCE VISION IN A SINGLE PROCEDURE SAN LEANDRO, Calif., June 18, 2013 /PRNewswire/ -- Cataracts are the leading cause of blindness in the world. According to the American Association of Ophthalmology, aging is the leading cause of eye diseases such as cataracts, a clouding of the eye's natural lens. 22 million Americans age 40 and older have cataracts, and by 2020, as Baby Boomers...
A Georgetown public health expert and attorney examines what the FDA must do to prevail When the US Food and Drug Administration (FDA) imposes new graphic warning labels for tobacco products, they can survive a First Amendment challenge if they depict health consequences and their effectiveness is supported by adequate scientific evidence, says a Georgetown University Medical Center public health expert and attorney. Graphic tobacco warning labels—which combine images with health...
According to a court order issued on March 20, a settlement has been reached in a Wright Profemur hip lawsuit alleging that the implant failed. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Wright Hip Implant serious complications. San Diego, CA (PRWEB) June 17, 2013 AttorneyOne.com, a recognized authority on law, updated the website...
The American Society of Addiction Medicine (ASAM) will release the most comprehensive report on the effectiveness of medications for opiate addiction and on the arbitrary restrictions on these FDA-approved drugs by many state governments and insurance companies. Safe and effective medications to treat opiate addiction are seriously under-utilized, resulting in preventable suffering and death. Washington (PRWEB) June 17, 2013 The American Society of Addiction Medicine (ASAM) will release...
New report shows increasing restrictions on addiction medications WASHINGTON, June 17, 2013 /PRNewswire-USNewswire/ -- The American Society of Addiction Medicine (ASAM) will release the most comprehensive report on the effectiveness of medications for opioid addiction and on the arbitrary restrictions on these FDA-approved drugs by many state governments and insurance companies. Drug overdoses now kill more Americans than drunk driving car crashes, an epidemic led by misuse of opioid...
- Amended protocol includes enhanced blood pressure monitoring to ensure optimal patient management - FRAMINGHAM, Mass., and SYDNEY, June 17, 2013 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has granted conditional approval to an IDE...
Agreement is the first to emerge under exclusive partnership between Imprimis Pharmaceuticals and Professional Compounding Centers of America (PCCA); acquisition allows Imprimis to begin to develop certain innovations created by Ohio-based compounding pharmacy. SAN DIEGO, Calif., June 17, 2013 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (NASDAQ:IMMY) today announced it has completed the acquisition of intellectual property (IP) rights related to certain proprietary innovations...
Dr. Walter Wood of First Coast Periodontics, P.A. now offers the first FDA cleared laser gum surgery to patients in Jacksonville, FL. The Laser Assisted New Attachment Procedure (LANAP) removes existing gum disease and helps patients with missing teeth have a healthy mouth for dental implants. Jacksonville, FL (PRWEB) June 16, 2013 Dr. Walter Wood of First Coast Periodontics, P.A. now offers the Laser Assisted New Attachment Procedure (LANAP), a non-invasive alternative to the traditional...
Published in the Journal for ImmunoTherapy of Cancer, review offers recommendations for manufacturing, pre-clinical studies, and clinical trial designs of cancer immunotherapies Milwaukee, WI (PRWEB) June 14, 2013 A picture of what the FDA is looking for in cancer immunotherapy product development appears in an extensive review article published in the inaugural issue of the Journal for ImmunoTherapy of Cancer. This review outlines a series of recommendations from the FDA, including cited...
NEW YORK, June 14, 2013 /PRNewswire/ -- IntelliCell BioSciences, Inc. ("Company") (OTC Pink: SVFC) announced today that on May 14, 2013 through June 2, 2013, its cellular laboratory facility underwent a thorough inspection by the FDA. The observations from the FDA inspection were provided to the company in the Form 483. The Company will respond to those observations in a timely manner. IntelliCell will take the necessary actions to address the relevant FDA observations....
